Levetiracetam may be more effective for late-onset partial epilepsy

Archives of Neurology

Volumn 59, Issue 12, 2002, Pages 1905-1908

  Bazil, Carl W ^a   Rose, Andrew ^a   Resor, Stanley ^a   Yapicular, Bülent ^a   Hirsch, Lawrence J ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ETIRACETAM;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG CHOICE; DRUG EFFICACY; FEMALE; FOCAL EPILEPSY; FRONTAL LOBE EPILEPSY; HUMAN; MALE; MEDICAL RECORD; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEIZURE; SIDE EFFECT; TEMPORAL LOBE EPILEPSY; TREATMENT INDICATION; TREATMENT OUTCOME;

ADULT; AGE OF ONSET; ANTICONVULSANTS; EPILEPSIES, PARTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PIRACETAM; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; VERBAL LEARNING;

EID: 0036895001     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.59.12.1905     Document Type: Article

References (19)

1. Mattson RH, Cramer JA, Collins JF, et al. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonicclonic seizures. N Engl J Med. 1985;313:145-151.
2. Bill PA, Vigonius U, Pohlmann H, et al. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy. Epilepsy Res. 1997;27:195-204.
3. Guerreiro MM, Vigonius U, Pohlmann H, et al. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy. Epilepsy Res. 1997;27:205-213.
4. Reinikainen KJ, Keranen T, Halonen T, Komulainen H, Riekkinen PJ. Comparison of oxcarbazepine and carbamazepine: A double-blind study. Epilepsy Res. 1987;1:284-289.
5. Christe W, Kramer G, Vigonius U, et al. A double-blind controlled clinical trial: Oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy. Epilepsy Res. 1997;26:451-460.
6. Lindberger M, Alenius M, Frisen L, et al, for the GREAT (Gabapentin in Refractory Epilepsy Add-on Treatment) Study Investigators Group. Gabapentin versus vigabatrin as first add-on for patients with partial seizures that failed to respond to monotherapy: A randomized, double-blind, dose titration study. Epilepsia. 2000; 41:1289-1295.
7. Brodie MJ, Richens A, Yuen AW, for the UK Lamotrigine/Carbamazepine Monotherapy Trial Group. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. Lancet. 1995;345:476-469.
8. Steiner TJ, Dellaportas C, Findley LJ, et al. Lamotrigine monotherapy in newly diagnosed untreated epilepsy: A double-blind comparison with phenytoin. Epilepsia. 1999;40:601-607.
9. Tassinari CA, Michelucci R, Chauvel P, et al. Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy. Epilepsia. 1996;37:763-768.
10. Faught E, Wilder BJ, Ramsay RE, et al, for the Topiramate YD Study Group. Topiramate placebo controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily doses. Neurology. 1996;46:1684-1690.
11. Beydoun A, Sachdeo RC, Rosenfeld WE, et al. Oxcarbazepine monotherapy for partial onset seizures: A multicenter, double-blind, clinical trial. Neurology. 2000;54:2245-2251.
12. Schachter SC, Vazquez B, Fisher RS, et al. Oxcarbazepine: Double-blind, randomized, placebo-control, monotherapy trial for partial seizures. Neurology. 1999;52:732-737.
13. Eckardt KM, Steinhoff BJ. Nonconvulsive status epilepticus in two patients receiving tiagabine treatment. Epilepsia. 1998;39:671-674.
14. Cereghino JJ, Biton V, Abou-Khalil B, Dreifuss F, Gauer LJ, Leppik I. Levetiracetam for partial seizures: Results of a double-blind, randomized clinical trial. Neurology. 2000;55:236-242.
15. Shorvon SD, Lowenthal A, Janz D, Bielen E, Loiseau P, for the European Levetiracetam Study Group. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. Epilepsia. 2000;41:1179-1186.
16. Genton P, Gelisse P. Antimyoclonic effect of levetiracetam. Epileptic Disord. 2000;2:209-212.
17. Hauser WA. Incidence and prevalence. In: Engel J, Pedley TA, eds. Epilepsy: A Comprehensive Textbook. Philadelphia, Pa: Lippincott-Raven; 1997:47-57.
18. Herman ST, Walczak TS, Bazil CW. Distribution of partial seizures during the sleep-wake cycle: Differences by seizure onset site. Neurology. 2001;56:1453-1459.
19. McCabe PH, McNew CD, Michel NC. Effect of divalproex-lamotrigine combination therapy in frontal lobe seizures. Arch Neurol. 2001;58;1264-1268.